Stefanie Fischer

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Induced Pluripotent Stem Cells

Epidermal Growth Factor Receptor

Tyrosine Kinase

Positive Breast Cancer

Top Venues

JCO precision oncology

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

William Kevin Kelly, Daniel Costin Danila, Chia-Chi Lin, Jae Lyun Lee, Nobuaki Matsubara, Patrick J Ward, Andrew J Armstrong, David W Pook, Miso Kim, Tanya Barauskas Dorff, Stefanie Fischer, Yung-Chang Lin, Lisa G Horvath, Christopher Sumey, Zhao Yang, Gabor Jurida, Kristen M Smith, Jamie N Connarn, Hweixian Leong Penny, Julia Stieglmaier, Leonard J Appleman
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study. Cancer discovery (2023)
Stefanie Fischer, Thorsten O Götze, Aurelius G Omlin, Richard D Baird, Keith M Dawson, Christof Zitt, Zita Arany, Gaby Tresch, Ulrike Fiedler, Simone Jeger, Samson Fung, Philippe Legenne, Nicolas Leupin, Andreas Schneeweiß, Carlo Fremd
A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab. JCO precision oncology 6 (2022)